StockData
ADMA Biologics, Inc. logo

ADMA Biologics, Inc. (ADMA) stock

ADMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3028% below fair value
$13.63+0.16 (+1.19%)

Close on Nov 17, 2026Market cap $3.05BP/E 19.5Yield –

ADMA Biologics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

ADMA Biologics's total debt was $196.59M at Jun 30, 2026. For fiscal 2025 it was $72.14M, down 0.3% from the year before. Over ten years it grew 34.3% a year on average. The highest annual figure on record is $92.97M in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$72.14M-0.3%
FY2024Dec 31, 2024$72.34M-22.2%
FY2020Dec 31, 2020$92.97M+36.1%
FY2019Dec 31, 2019$68.29M+158.3%
FY2018Dec 31, 2018$26.44M+4.2%
FY2017Dec 31, 2017$25.37M+105.9%
FY2016Dec 31, 2016$12.32M-13.5%
FY2015Dec 31, 2015$14.25M-2.2%
FY2014Dec 31, 2014$14.57M+199.4%
FY2013Dec 31, 2013$4.87M+28.9%
FY2012Dec 31, 2012$3.77M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$196.59M+171.8%
Q1 FY2026Mar 31, 2026$196.87M+110.7%
Q4 FY2025Dec 31, 2025$72.14M-22.4%
Q3 FY2025Sep 30, 2025$72.43M-11.8%
Q4 FY2024Dec 31, 2024$72.34M-11.4%
Q1 FY2021Mar 31, 2021$93.41M+15.0%
Q4 FY2020Dec 31, 2020$92.97M+36.1%
Q3 FY2020Sep 30, 2020$82.11M+21.0%
Q2 FY2020Jun 30, 2020$81.65M+21.0%
Q1 FY2020Mar 31, 2020$81.21M+98.6%
Q4 FY2019Dec 31, 2019$68.29M+158.3%
Q3 FY2019Sep 30, 2019$67.84M+159.4%
Q2 FY2019Jun 30, 2019$67.47M+160.7%
Q1 FY2019Mar 31, 2019$40.89M+59.6%
Q4 FY2018Dec 31, 2018$26.44M+4.2%
Q3 FY2018Sep 30, 2018$26.15M+79.9%
Q2 FY2018Jun 30, 2018$25.88M+176.5%
Q1 FY2018Mar 31, 2018$25.62M+136.2%
Q4 FY2017Dec 31, 2017$25.37M+105.9%
Q3 FY2017Sep 30, 2017$14.53M+5.4%
Q2 FY2017Jun 30, 2017$9.36M–
Q1 FY2017Mar 31, 2017$10.85M–
Q4 FY2016Dec 31, 2016$12.32M–
Q3 FY2016Sep 30, 2016$13.79M–

More ADMA Biologics figures

See a number that looks wrong?